Advertisement
Advertisement

IMMX

IMMX logo

Immix Biopharma, Inc. Common Stock

9.91
USD
Sponsored
+0.51
+5.43%
Jun 23, 16:00 UTC -4
Closed
exchange

After-Market

9.90

-0.01
-0.14%

Immix Biopharma, Inc. Common Stock Profile

About

Immix Biopharma Inc. is a biopharmaceutical company pioneering Tissue Specific Therapeutics (TM) targeting oncology and immuno-dysregulated diseases. Immix Biopharma Inc. is based in LOS ANGELES.

Info & Links

CEO

Ilya Rachman

Headquarters

11400 WEST OLYMPIC BLVD, SUITE 200
LOS ANGELES, CA 90064, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.immixbio.com

Auditor

Crowe LLP

Share holders

43

Employees

21

Immix Biopharma, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

704.50M

Enterprise Value

625.25M

Enterprise Value/EBITDA(ttm)

-17.54

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

5.50

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-101.25%

Return on Invested Capital(ttm)

-292.85%

Return on Assets(ttm)

-73.39%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-35.64M

Net Income Available to Common(ttm)

-34.98M

Diluted EPS(ttm)

-0.89

Share Statistics

Beta (5Y Monthly)

0.20

52-Week Change

342.41%

S&P 500 52-Week Change

20.90%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

54.41M

Dividend Yield

0.00%

Float4

23.64M

% Held by Insiders

55.40%

% Held by Institutions

11.26%

Balance Sheet

Total Cash(mrq)

90.58M

Total Cash Per Share(mrq)

1.66

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

10.01%

Quick Ratio(mrq)

10.01%

Book Value Per Share(mrq)

1.77

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.73

Free Cash Flow(ytd)

-24.66M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement